严重功能障碍对多达维 (ONC201) 药理动学的影响
Shamia L Faison1, Joelle Batonga1, Thangam Arumugham2
1Certara Strategic Consulting, Randor, PA, USA.
Drugs in R&D
|July 31, 2025
概括
在患有严重功能障碍 (RI) 的患者中,多达维 (ONC201) 暴露增加了约50%,表明CYP3A4活性降低. 这一发现对于在RI患者中调整多尔达维的剂量至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 多达维 (ONC201) 是一种小分子药物,在质瘤患者中具有抗瘤活性.
- 多尔达维脱离的主要途径是通过细胞染色体P450 3A4 (CYP3A4) 的代谢.
- 严重功能障碍 (RI) 对多尔达维的药理动学的影响以前没有被评估.
研究的目的:
- 评估多尔达维在患有严重功能障碍的人群中的药理动力学概况.
- 为了比较dordaviprone暴露和严重RI患者的安全性,与健康对照对比.
- 在功能受损的患者中为多尔达维的潜在剂量调整提供信息.
主要方法:
- 一次口服剂量为375毫克的多达维给了八名严重RI的参与者和八名健康的匹配对照.
- 血和尿液样本被采集并使用验证的液体染色学 (tandem mass spectrometry) 来分析.
- 对两个队列的药理动力学参数,血蛋白结合和安全性资料进行了评估.
主要成果:
- 通过AUClast和AUCinf测量的多达维暴露,与健康对照人相比,在患有严重RI的参与者中大约高出48%.
- 多尔达维的脏清除是可以忽略不计的,在严重的RI和健康的队列之间是相似的.
- 与多达维相关的轻度不良事件在50%的严重RI参与者和37.5%的健康参与者中被观察到.
结论:
- 严重的功能障碍导致多达维暴露的显著增加,可能是由于抑制了CYP3A4代谢活动.
- 尽管干净度很小,但在严重的RI中,多达维的药理动力学会发生变化.
- 这些发现需要仔细考虑多达维在功能障碍患者的剂量策略.
相关概念视频
01:11Renal Failure: Dose Adjustments
161
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
161
01:17Factors Affecting Renal Clearance: Renal Impairment
162
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
162
01:15Renal Drug Excretion: Overview
283
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
283
01:22Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
277
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
277
01:06Renal Drug Clearance: Overview
338
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
338
01:28Renal Drug Excretion: Tubular Secretion
363
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
363